Differences in pupil sizes distinguish between active and resolved COVID-19 cases

Article

The investigators believe that, based on their findings, the impact of COVID-19 on the autonomous nervous system warrants further prospective studies and assessment of pupillary function might be a useful test for determining autonomic dysfunction.

 Differences in pupil sizes distinguish between active and resolved COVID-19 cases

Active COVID-19 can affect the pupillary diameter, according to Turkish investigator Dr Serap Yurttaser Ocak and colleagues, who reported finding significant differences in the pupillary diameters between when the virus was active and 3 months later.1

The authors are from the Department of Ophthalmology, Prof. Dr Cemil Tascioglu Education and Research Hospital, University of Health Sciences, Istanbul, Turkey.

The researchers conducted a study that included 58 patients (mean age, 47.23 ± 1.1 years) with active COVID-19 infections. The scotopic, mesopic, and photopic pupillary diameters were measured at subsequent time points after the light source was terminated, that is, at 0, 1, 2 4, 6, 8, and 10 seconds. The average speed at which the dilation occurred also was determined at 1, 2, 4, 6, 8, and 10 seconds. These measurements then were compared in the same patients 3 months later.

The study showed that the mean scotopic and mesopic diameters were less during active infections compared with 3 months after the infection (p = 0.001 and p = 0.023, respectively).

There were no significant differences in the mean photopic pupillary diameter and the mean pupillary diameter at 0 seconds between measurements (p > 0.05, p = 0.734; respectively).

The mean pupillary diameters were significantly lower during active infection at 1, 2, 4, 6, 8, and 10 seconds (p < 0.01, for all comparisons), and the average speeds at which the pupils dilated at each time point were lower during active infection compared with the measurements at 3 months (p = 0.001; p < 0.01 for each).

The investigators believe that, based on their findings, the impact of COVID-19 on the autonomous nervous system warrants further prospective studies and assessment of pupillary function might be a useful test for determining autonomic dysfunction.

Reference
Ocak SY, Ozturan SG, Bas E. Pupil responses in patients with COVID-19. Int Ophthalmol 2021; doi: https://doi.org/10.1007/s10792-021-02053-z

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Related Content
© 2025 MJH Life Sciences

All rights reserved.